Activity of voltage-gated potassium (Kv) channels controls membrane potential, which subsequently regulates cytoplasmic free calcium concentration ([Ca 2+ ] cyt ) in pulmonary artery smooth muscle cells (PASMCs). Acute hypoxia inhibits Kv channel function in PASMCs, inducing membrane depolarization and a rise in [Ca 2+ ] cyt that triggers vasoconstriction. Prolonged hypoxia inhibits expression of Kv channels and reduces Kv channel currents in PASMCs. The consequent membrane depolarization raises [Ca 2+ ] cyt , thus stimulating PASMC proliferation. The present review discusses recent evidence for the involvement of Kv channels in initiation of hypoxic pulmonary vasoconstriction and in chronic hypoxia-induced pulmonary hypertension. [Ca 2+ ] cyt = cytoplasmic calcium concentration; E m = membrane potential; HPV = hypoxic pulmonary vasoconstriction; I K(V) = potassium currents through potassium channels; K Ca = calcium-activated potassium channel; K ATP = ATP-sensitive potassium channel; Kv = voltage-gated potassium channel; NO = nitric oxide; PASMC = pulmonary artery smooth muscle cell; SMC = smooth muscle cell; VDCC = voltage-dependent calcium channel.
Introduction
The main function of the low-pressure, low-resistance pulmonary circulation is to oxygenate blood to be supplied to the rest of the body. In order to perform this function efficiently, the lung must match its regional ventilation and perfusion. Thus, in regions where alveolar oxygen levels are low the pulmonary arteries constrict, diverting blood flow to better ventilated areas of the lung where gas exchange can take place more efficiently. This important physiologic phenomenon is known as 'hypoxic pulmonary vasoconstriction' (HPV), and is unique to the pulmonary circulation; hypoxia generally causes dilatation in systemic arterial beds.
In the fetus, gas exchange occurs via the placenta and HPV acts to maintain a high pulmonary vascular resistance to divert blood flow away from the lungs through the ductus arteriosus. In the adult, HPV can act as a protective mechanism during acute exposure to hypoxia in order to maintain ventilation-perfusion matching (eg during an acute asthma attack). Chronic exposure to hypoxia (eg chronic obstructive pulmonary disease or living at high http://respiratory-research.com/content/1/1/040 commentary review reports primary research altitude) causes continuous alveolar hypoxia, which results in sustained HPV, leading to vascular remodeling, pulmonary hypertension, and possibly right heart failure and death.
The mechanism that is responsible for HPV has still not been fully elucidated. The present review concentrates specifically on summarizing the knowledge gained, during the past 10 years, regarding the role of Kv channels in initiation of the acute and chronic responses of pulmonary arteries to hypoxia. Also briefly summarized are some of the mechanisms that underlie current treatment of hypoxiarelated cardiopulmonary disease states.
Acute hypoxic pulmonary vasoconstriction
In whole animals, or isolated lungs, acute exposure to hypoxia causes a sustained increase in pulmonary arterial pressure. Hypoxia also causes contraction in isolated pulmonary arteries [1] [2] [3] and single PASMCs [4, 5] . In contrast, hypoxia causes relaxation of cerebral arterial smooth muscle cells (SMCs) [4] . These findings indicate that the mechanism of HPV is intrinsic to the vascular wall of pulmonary arteries, and imply that the effects of neural inputs, blood-borne agents, and lung parenchyma do not directly mediate HPV, but rather they modulate the response.
Removal of the endothelium does not abolish hypoxiamediated contraction in isolated pulmonary arteries [3] . The observations of hypoxia-induced contraction in single PASMCs imply that the endothelium is not necessary for HPV, and that all of the mechanisms that are necessary for sensing and responding to hypoxia are intrinsic to the PASMC [4, 5] . It is generally accepted that the endothelium does modulate HPV. This effect could be achieved through release of endothelium-derived contracting factors (eg endothelin-1 or thromboxane A 2 ) or through reduction of vasodilator activity of endothelium-derived relaxing factors (eg nitric oxide [NO] and prostacyclin) and endothelium-derived hyperpolarizing factors.
Role of intracellular calcium
An increase in [Ca 2+ ] cyt is necessary to elicit contraction in smooth muscle. In PASMCs, [Ca 2+ ] cyt can be increased by calcium influx through sarcolemmal calcium channels and by its release from intracellular stores (mainly sarcoplasmic reticulum). There are at least three classes of calcium-permeable channels in the plasma membrane: voltage-dependent calcium channels (VDCCs), receptoroperated calcium channels, and store-operated calcium channels. Calcium influx through VDCCs is governed by the membrane potential (E m ). VDCCs are normally closed at resting E m , but when the membrane is depolarized they open, allowing calcium influx into the cells [6, 7] .
McMurtry et al [8] demonstrated that blockers of calcium channels reduced the hypoxic response in isolated lungs, indicating that a rise in [Ca 2+ ] cyt is a necessary step in HPV. Subsequent studies in isolated PASMCs, using fluorescence microscopy techniques, have shown that hypoxia does cause an increase in [Ca 2+ ] cyt [9, 10] . This increase in [Ca 2+ ] cyt is smaller in the absence of extracellular calcium, implying contributions from calcium release from intracellular stores and calcium entry across the sarcolemma. The partial inhibition of HPV by the VDCC blocker verapamil [8] suggested that hypoxia must cause opening of VDCCs, implying that membrane depolarization would also appear to be a necessary step in the hypoxic response. Harder et al [1] and Madden et al [2] demonstrated that hypoxia does indeed induce membrane depolarization and elicits calcium-dependent action potentials in cat pulmonary arteries.
Taken together, the results of these studies indicate that initial depolarization is necessary for opening of VDCCs to allow influx of calcium into PASMCs and to elicit HPV. They also imply that one or more of the potassium channels involved in regulating E m in PASMCs must be sensitive to hypoxia, and could be involved in initiating HPV. These findings have led to a considerable body of research concerned with identifying the particular potassium channel(s) that are involved and the mechanism by which changes in oxygen tension are sensed by the channel(s).
Regulation of membrane potential in pulmonary artery smooth muscle cells E m in vascular SMCs is predominantly controlled by potassium permeability, which is determined by sarcolemmal potassium channel conductance and transmembrane potassium gradient. Intracellular potassium concentration (140 mmol/l) is greater than that of extracellular potassium (5 mmol/l), favoring movement of potassium out of the cell when potassium channels are open, leading to hyperpolarization of the membrane. Closure of these channels would cause membrane depolarization, leading to opening of VDCCs and entry of calcium into the cell. To date, three types of potassium channels have been described in PASMCs: Kv channels [7,11 • ,12 • ], calcium-activated potassium (K Ca ) channels [13, 14] , and ATP-sensitive potassium (K ATP ) channels [6] . Potassium currents through all three of these channel types contribute to the regulation of E m [6] . Using the Kv channel blocker 4-aminopyridine, it has been shown [7,9,11 • ,12 • ,15] that potassium currents through Kv channels (I K(V) ) are the major determinants of resting E m in PASMCs.
Effect of hypoxia on I K(V)
Post et al [16 •• ] Fig. 1a and b) . The resultant membrane depolarization leads to opening of VDCCs, allowing calcium influx into the cells to increase [Ca 2+ ] cyt ( Fig. 1c and d ). This hypoxic inhibition of I K(V) is selective to PASMCs, because acute hypoxia has negligible effects on I K(V) in mesenteric arterial SMCs (Fig. 1b) .
Molecular identity of Kv channels
At the molecular level, Kv channels are homo-or heteromultimeric tetramers that are composed of two structurally distinct subunits: the pore-forming α-subunits and the regulatory β-subunits. The genes that encode functional Kv channel α-subunits fall into four subfamilies: Shaker (Kv1), Shab (Kv2), Shaw (Kv3), and Shal (Kv4). At least 25 vertebrate genes that encode functional Kv channel α-subunits have been isolated from mammals, and more than 15 genes from humans. Each of these Kv channel α-subunits produces functionally distinct Kv channels. Recently, four new subfamilies of electrically silent Kv channel α-subunits have been cloned: Kv5, Kv6, Kv8, and Kv9. Expression of these modulatory α-subunits per se does not produce potassium channel activity; however, coexpression of these modulatory α-subunits with other functional Kv channel α-subunits (eg Kv2.1) significantly modulates biophysical properties (eg activation and inactivation kinetics, voltage dependence) and expression levels of the functional Kv channels [20 
Three subfamilies of Kv channel β-subunits -Kvβ1, Kvβ2, and Kvβ3 -have been identified in mammalian tissues [21, 22] . Although expression of α-subunits alone is sufficient to generate Kv channels that possess many features of the corresponding channels in situ, studies on native channels have confirmed that the biophysical properties of Kv channels encoded by certain α-subunits can be dramatically altered by their association with β-subunits. For example, association of β-subunits with α-subunits can confer fast inactivation on slowly inactivating or noninactivating delayed rectifier Kv channels [22] , and determines the response of the α-subunits to activated protein kinases. In addition to changing kinetic properties of Kv channels, β-subunits can also reduce I K(V) as an openchannel blocker.
Molecular identity of the Kv channels that are responsible for the hypoxia-sensitive I K(V)
The potential candidate Kv channel α-subunits that could form oxygen-sensitive, homomeric or heteromeric channels include Kv1 [Ca 2+ ] cyt measured (using Fura-2) in a peripheral cytoplasmic region of a PASMC on switching from normoxic to hypoxic bath solutions. The PO 2 level was measured using an oxygen meter positioned in the tissue chamber. Modified with permission from Yuan et al [19 [29] . Qualitative differences in Kv channel α-subunits between PASMCs and systemic artery SMCs have not thus far been observed, but their divergent responses to hypoxia have been well documented. Therefore, why hypoxia only inhibits the aforementioned Kv channels in PASMCs, but not in systemic artery smooth muscle requires further investigation.
Possible mechanisms involved in oxygen sensing
Kv channels have also been implicated in sensing hypoxia in other oxygen-sensitive cells, including cells of the carotid and aortic bodies and neuroepithelial cells [30] . Multiple pathways may exist for hypoxia-induced Kv channel inhibition, and the mechanisms of hypoxia-induced inhibition of potassium currents in oxygen-sensitive cells may be similar. Acute hypoxia may inhibit Kv channel function by the following mechanisms: inhibiting oxidative phosphorylation [31] ; changing redox status [17,28 • ,31] ; altering a membrane-delimited oxygen-sensitive regulatory moiety that is adjacent or coupled to the channel protein [30, 32] ; activating mitochondrial NAD(P)H oxidase and increasing superoxide production [33, 34] ; inhibiting cytochrome P450 [7] ; decreasing intracellular pH [35] ; releasing calcium from intracellular stores [8,12 • ]; and affecting directly the Kv channel protein [30] . 
Chronic hypoxic pulmonary vasoconstriction: role of Kv channels
In lungs from chronically hypoxic rats, the pressor response to acute hypoxia is impaired, whereas the pressor response to vasoconstrictor agonists (eg angiotensin II, prostaglandin F 2α , and norepinephrine) is enhanced [36] . These observations suggest that the reduced pressor response to acute hypoxia in chronically hypoxic rats may result from abnormalities in the mechanism that couples acute hypoxia to contraction of the pulmonary vascular smooth muscle. That is, chronic hypoxia-mediated pulmonary hypertension may involve the same mechanisms as those responsible for acute HPV. Accordingly, a reduction in the activity of Kv channels in PASMCs, with the resultant membrane depolarization, may be involved in the development of chronic hypoxiamediated pulmonary hypertension by mediating pulmonary vasoconstriction and vascular remodeling through increased [Ca 2+ ] cyt in PASMCs. Consistent with its inhibitory effect on Kv channel expression, prolonged hypoxia reduces I K(V) (Fig. 3a and b ) and depolarizes PASMCs (Fig. 3d) Chronic hypoxia has little effect on systemic arterial pressure, measured via a catheter positioned in the carotid artery (Yuan, unpublished data). In mesenteric arterial SMCs, chronic hypoxia did not significantly alter the expression of the Kv channel α-or β-subunits examined ( Fig. 2d ; Yu and Yuan, unpublished data). Also, in these cells I K(V) was slightly increased (Fig. 3c) and E m was hyperpolarized ( Fig. 3d ; Platoshyn and Yuan, unpublished data).
Cellular and molecular mechanisms mediating the effects of chronic hypoxia
As discussed above, it appears that hypoxia regulates the function of Kv channel α-subunits via an intrinsic mechanism that exists uniquely in PASMCs. The selectivity of hypoxia-induced downregulation of Kv channel expression and reduction in I K(V) in PASMCs suggests that the molecular mechanisms involved in the regulation of Kv channel gene expression are quite different between pulmonary and systemic arterial SMCs.
The common pathways that transduce hypoxic signals from the sensor to appropriate gene expression involve phosphorylation and/or redox modification of responsive transcription factors [40] . Hypoxia can modulate a variety of transcription factors and signal transduction signaling proteins, such as HIF-1, nuclear factor-κB, c-fos/c-jun, p53, KBF, c/EBP, FixL, and FixJ, suggesting that a large number of transcriptional systems contribute to the response to hypoxia [40] [41] [42] .
Chronic hypoxia may inhibit Kv channel activity by directly or indirectly downregulating mRNA and protein expression of Kv channel α-subunits. In addition to the mechanisms by which acute hypoxia decreases Kv channel activity, the underlying mechanisms that are involved in chronic hypoxia-induced reduction in Kv channel expression may include the following: upregulation or downregulation of the transcription factors and signal transduction proteins [40] that can directly bind to the Kv channel gene promoters (eg Kv1.5 repressor element) and modulate the Kv channel gene transcription [41, 42] ; and induction of transcription factors that upregulate intermediate inhibitors of the Kv channel genes, such as endothelin-1 [38, 39] . Preliminary results from our laboratory (Platoshyn et al, unpublished data) have shown that overexpression of c-jun significantly decreased whole-cell I K(V) in rat PASMCs.
Whether the hypoxia-sensitive transcription factors have direct and/or indirect modulatory effects on gene transcription of Kv channels in PASMCs is unclear and requires further study. Another possibility is that acute hypoxia decreases I K(V) by inhibiting Kv channel activity in PASMCs, with the resultant membrane depolarization attenuating Kv channel expression [43] . The precise mechanisms that are responsible for the differing effects of hypoxia on gene expression of Kv channels in pulmonary and mesenteric artery SMCs may underlie the upstream regulation of the Kv channel gene promoter.
Therapeutic approaches in hypoxia-mediated pulmonary hypertension
Acute HPV can be beneficial in vivo, but over a prolonged period it can be dangerous, leading to persistent elevation of pulmonary vascular resistance and vascular remodeling, pulmonary hypertension, right ventricular failure, and possibly death. Therefore, inhibition of HPV is a potentially useful therapeutic mechanism for patients with pulmonary hypertension secondary to hypoxic pulmonary diseases (eg chronic obstructive pulmonary diseases, Eisenmenger's syndrome, and mountain sickness).
Calcium channel blockers
McMurtry et al [8] first showed that the calcium channel blocker verapamil inhibited HPV in isolated rat lungs. Membrane depolarization-mediated influx of calcium into PASMCs during hypoxia is necessary for both vasoconstriction and cell proliferation. Calcium channel blockers, which have been shown to inhibit HPV in intact animals and isolated perfused lungs, have been used clinically (administered intravenously or orally) to reverse HPV, because they prevent calcium influx into cells and thus inhibit pulmonary vasoconstriction.
Nitric oxide and prostacyclin activate potassium channels in PASMCs
NO and prostacyclin are potent endothelium-derived relaxing factors and inhibitors of SMC proliferation. Inhalation of NO and intravenous administration of prostacyclin have been shown to be effective in inhibiting HPV. NO exerts its vasodilator effect in part by activating K Ca and Kv channels, which subsequently causes membrane hyperpolarization, decreases resting [Ca 2+ ] cyt , and elicits vasodilatation [44, 45] . This activation of K Ca and Kv channels can be directly mediated by the nitrosylation or oxidization effect on the channel protein, and/or indirectly mediated by the increase in cGMP production [44, 45] . In PASMCs, NO can also decrease [Ca 2+ ] cyt by the following mechanisms: inhibiting agonist-induced calcium release; blocking VDCCs; and enhancing calcium extrusion and sequestration into the sarcoplasmic reticulum. Prostacyclin may cause vasodilatation by partially activating K Ca channels in PASMCs [46] . These results suggest that the therapeutic effects of NO and prostacyclin may be, at least in part, due to membrane hyperpolarization induced by enhancement of potassium currents through K Ca and Kv channels, and the subsequent reduction in [Ca 2+ ] cyt in PASMCs.
In animals, endothelin receptor antagonists have been shown to attenuate acute HPV and reverse or protect against the development of pulmonary hypertension and associated vascular remodeling [47] . BQ-123, a specific endothelin A receptor antagonist, showed selectivity for the pulmonary circulation, because it did not affect systemic arterial pressure [47] . The action of BQ-123 has been at least partly attributed to its ability to prevent endogenous endothelin from inhibiting potassium channels [39] .
Potassium channel openers
Opening of potassium channels is a physiologic mechanism for reversing hypoxia-induced membrane depolarization, and thereby reversing depolarization-induced contractions. Synthetic potassium channel openers have been identified that open K ATP or K Ca channels. However, there are not yet specific potassium channel openers for Kv channels, which are the channels that are actually inhibited by hypoxia. Lemakalim has been shown to open K ATP channels in PASMCs [6] . Recently, Peng et al [14] demonstrated that the novel K Ca opener dehydroepiandrosterone, an endogenously produced hormone, reversed the chronic hypoxia-induced reduction in potassium currents through K Ca channels in human PASMCs. Archer et al [48] demonstrated differential distribution of potassium channels in pulmonary arteries, with the smaller resistance arteries, which are most sensitive to hypoxia, having fewer K Ca channels than the conduit pulmonary arteries. However, because K Ca channels have a large unitary conductance (200-250 pS), opening of only a few K Ca channels would have a significant effect on E m and would be a very efficient mechanism for reversing HPV. With the recent advances in molecular identification of specific potassium channel subunits in PASMCs, it should soon be possible to design new potassium channel openers that are selective for specific pulmonary potassium channels.
The current clinical therapies are aimed at reversing the pathophysiologic symptoms of hypoxia, which are principally vasoconstriction and cell proliferation. Current research is aimed at molecular identification of the oxygen sensor in the PASMC, and the cellular mechanisms of transduction of the hypoxic signal to effect HPV and PASMC proliferation. Identification of these mechanisms should enable the development of new, selective treatments for hypoxia-related cardiopulmonary disease states.
Conclusion
Ion channels are involved in regulation of vascular tone in physiologic and pathophysiologic conditions. Disruption of [Ca 2+ ] cyt homeostasis, caused by defects in ion channels, appears to be involved in the pathology of many cardiovascular diseases, including hypoxic pulmonary hypertension. Hypoxia may inhibit Kv channels via multiple pathways in order to assure the efficacy and sensitivity of HPV. Acute hypoxia selectively inhibits Kv channel function and induces E m depolarization in PASMCs, and the resultant increase in [Ca 2+ ] cyt triggers HPV. Chronic hypoxia selectively inhibits mRNA and protein expression of the Kv channel α-subunits (the pore-forming subunits) and decreases the number of functional Kv channels in PASMCs. The consequent reduction in I K(V) depolarizes PASMCs, raises [Ca 2+ ] cyt , and stimulates cell proliferation. Ultimately, persistent pulmonary vasoconstriction and excessive vascular remodeling (via medial hypertrophy) increase pulmonary vascular resistance and cause pulmonary hypertension. Fig. 4 illustrates schematically the multiple pathways and modulators that are involved in effecting the physiologic and pathophysiologic responses to acute and chronic hypoxia. Further research into the mechanisms of HPV, the major contributing factor to the pulmonary hypertension that is present in a variety of
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Figure 4
Proposed mechanisms involved in HPV and vascular remodeling. EDRF, endothelium-derived relaxing factor; EDCF, endothelium-derived constricting factor; PGI 2 cardiopulmonary diseases, should lead to more effective treatment of these diseases.
